# Value of ctDNA in the Treatment of Multiple Primary Cancers

> **NCT05164510** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 40 (estimated)

## Conditions studied

- Multiple Primary Cancers

## Interventions

- **GENETIC:** ct-DNA guided therapy

## Key facts

- **NCT ID:** NCT05164510
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12
- **Primary completion:** 2022-09
- **Final completion:** 2023-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05164510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05164510, "Value of ctDNA in the Treatment of Multiple Primary Cancers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05164510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*